Connect with us

Hi, what are you looking for?

top
Capital News
Health Director-General Patrick Amoth said the country expects free 24 million doses which will cover 20 per cent of the population with an additional 12 million doses set to be procured at the cost of Sh10 billion to reach another 10 per cent/FILE

Capital Health

MoH preselects Oxford/AstraZeneca vaccine awaiting WHO greenlight

NAIROBI, Kenya, Dec 18 – The Ministry of Health has selected Oxford/AstraZeneca vaccine as its preferred COVID-19 immunization plan citing affordability and ease of storage under Kenya’s climatic conditions.

Health Director-General Patrick Amoth said the country expects free 24 million doses which will cover 20 per cent of the population with an additional 12 million doses set to be procured at the cost of Sh10 billion to reach another 10 per cent.

Speaking in Murang’a during the opening of Santamore Surgical Hospital, Amoth said the vaccine, which is yet to be approved by the World Health Organization (WHO), met the ministry’s vetting threshold.

“Under COVAX facility, Kenya is expected to get 24 million doses of the vaccine and we are looking at four parameters in a vaccine;  vector–carrier developed, WHO pre-qualified, and one that fits in the cold chain system of 2-8 degrees centigrade and one with lowest prices,” he said.

Kenya  is a signatory of the COVAX facility which was was created by GAVI, UNICEF and the WHO in search of one common vaccine.

The Health DG noted that the vaccine which is awaiting WHO greenlight will be prioritized to frontline healthcare workers, teachers and uniformed officers.

Among those who will benefit include frontline healthcare workers in both public and private health sector (1 percent of population), those above aged 50 years (10 per cent  of population), those with co-existing conditions(8 per cent of population), teachers and uniformed sec officers (2 per cent of population).

“Kenya participated in clinical trials of the vaccine,” Amoth noted adding the chosen vaccine has met all the parameters required and has shown good efficacy including safety .

Advertisement. Scroll to continue reading.

“It’s not going to be a silver bullet, we cannot immunize all Kenyans at a go, it’s imperative we continue to observe COVID-19 measures,” he added.

Amoth said Moderna and Pfizer vaccines which have been widely circulated in USA and UK following approval by WHO require unique cold chain storage systems which many countries do not have.

Click to comment
Advertisement

More on Capital News

County News

Sophie promised to mobilise her European colleagues in the industry to support needy children in the country.

World

Ciudad Victoria, Mexico, Jan 24 – At least 19 charred corpses have been discovered in Mexico near the US border in an area where...

Capital Health

Health Cabinet Secretary Mutahi Kagwe said the infections reported on Sunday were identified from 2,985 samples tested within 24 hours.

Capital Health

The period under review was characterized with an economic meltdown and job losses, with security officers being on spot for use of excessive force...

Fifth Estate

While its standard practice for running political parties in Kenya to remain brutal, cunning and complex, it is time we thought serious about allowing...

Capital Health

In the findings of a research conducted in 24 counties with a sample population of 800 respondents, the healthcare workers scored 70 per cent...

business

Sixty-five per cent of 800 respondents interviewed between December 27 and December 29 said government did not do a good job running the economy.

World

Caracas, Venezuela, Jan 24 – Venezuelan President Nicolas Maduro said Saturday he was willing to “turn the page” with the US under President Joe...